A Successful Treatment Approach in 2 Patients With Type 1 Plasminogen Deficiency: Intratracheal Application of Fresh Frozen Plasma and Tissue Plasminogen Activator.

Serdar Al Oktay Ulusoy Suna Asilsoy Nevin Uzuner Ozge Kangalli Özge Atay Işık Odaman Al Oguz Ates

Published in: Journal of pediatric hematology/oncology (2023)

Intratracheal administration of tissue plasminogen activator and FFP is an available treatment modality for patients with lung involvement. Fibrin plaques should be carefully removed and new lesion formation should be prevented.

Keyphrases

replacement therapy
combination therapy